| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99f5741a1adaef179e9a512599aaed95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d93eee70e1b36f13cc71fbf1737adb08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e59b927ef09c3f125c969c74a6b29c2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2014-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e6b6217ccdfb8782266d362a430ba5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2b2c1e09c955c56be9480e491d58558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_952ff9f0e79ea29cbd1c54ccdd1a1685 |
| publicationDate |
2015-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015044854-A1 |
| titleOfInvention |
Markers associated with mtor inhibition |
| abstract |
The present invention relates to methods predicting the sensitivity of a cancer patient for treatment with an mTOR inhibitor, the method comprising: a) obtaining a cancer sample from a HER2+ BC cancer patient, b) analyzing the cancer sample obtained from the patient for PTEN expression, c) optionally determining the status of PR/ER and d) administering an effective amount of the mTOR inhibitor to a patient with low PTEN level and optionally which is PR/ER negative |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108676882-A |
| priorityDate |
2013-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |